microRNA expression profile in human coronary smooth muscle cell-derived microparticles is a source of biomarkers;El perfil de expresión de microARN en micropartículas secretadas por células musculares lisas de arterias coronarias humanas es una fuente de biomarcadores

Clinica e Investigacion en Arteriosclerosis

Volumn 28, Issue 4, 2016, Pages 167-177

  de Gonzalo Calvo, David ^a   Cenarro, Ana ^b   Civeira, Fernando ^b   Llorente Cortes, Vicenta ^a  

^a BIOMEDICAL RESEARCH INSTITUTE SANT PAU IIB SANT PAU   (Spain)

^b HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

Author keywords

Biomarker; Cell derived microparticles; MicroRNAs; Vascular smooth muscle cell

Indexed keywords

BIOLOGICAL MARKER; CHOLESTEROL; CHOLESTEROL ESTER; FREE CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LOW DENSITY LIPOPROTEIN RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MICRORNA; MICRORNA 143 3P; MICRORNA 145 5P; MICRORNA 21 5P; MICRORNA 221 3P; MICRORNA 222 3P; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY MUSCLE; EXPLANT; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENDER; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN CORONARY ARTERY SMOOTH MUSCLE CELL; IN VITRO STUDY; MALE; MEMBRANE MICROPARTICLE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR SMOOTH MUSCLE CELL; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASES; CASE CONTROL STUDY; CELL CULTURE; CORONARY BLOOD VESSEL; CYTOLOGY; GENETICS; HYPERCHOLESTEROLEMIA; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; SMOOTH MUSCLE CELL;

ADULT; ATHEROSCLEROSIS; BIOMARKERS; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CELL-DERIVED MICROPARTICLES; CELLS, CULTURED; CORONARY VESSELS; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERLIPOPROTEINEMIA TYPE II; MALE; MICRORNAS; MIDDLE AGED; MYOCYTES, SMOOTH MUSCLE; PLAQUE, ATHEROSCLEROTIC; REAL-TIME POLYMERASE CHAIN REACTION; RISK FACTORS;

EID: 84979710985     PISSN: 02149168     EISSN: 15781879     Source Type: Journal    
DOI: 10.1016/j.arteri.2016.05.005     Document Type: Article

References (41)

1. 1 Mendell, J.T., Olson, E.N., MicroRNAs in stress signaling and human disease. Cell 148 (2012), 1172–1187.
2. 2 van Rooij, E., Sutherland, L.B., Qi, X., Richardson, J.A., Hill, J., Olson, E.N., Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 316 (2007), 575–579.
3. 3 Small, E.M., Olson, E.N., Pervasive roles of microRNAs in cardiovascular biology. Nature 469 (2011), 336–342.
4. 4 Mitchell, P.S., Parkin, R.K., Kroh, E.M., Fritz, B.R., Wyman, S.K., Pogosova-Agadjanyan, E.L., et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105 (2008), 10513–10518.
5. 5 Rayner, K.J., Hennessy, E.J., Extracellular communication via microRNA: lipid particles have a new message. J Lipid Res 54 (2013), 1174–1181.
6. 6 Hergenreider, E., Heydt, S., Treguer, K., Boettger, T., Horrevoets, A.J., Zeiher, A.M., et al. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol 14 (2012), 249–256.
7. 7 Bang, C., Batkai, S., Dangwal, S., Gupta, S.K., Foinquinos, A., Holzmann, A., et al. Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy. J Clin Invest 124 (2014), 2136–2146.
8. 8 Shan, Z., Qin, S., Li, W., Wu, W., Yang, J., Chu, M., et al. An endocrine genetic signal between blood cells and vascular smooth muscle cells: role of microRNA-223 in smooth muscle function and atherogenesis. J Am Coll Cardiol 65 (2015), 2526–2537.
9. 9 Creemers, E.E., Tijsen, A.J., Pinto, Y.M., Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease?. Circ Res 110 (2012), 483–495.
10. 10 Romaine, S.P., Tomaszewski, M., Condorelli, G., Samani, N.J., MicroRNAs in cardiovascular disease: an introduction for clinicians. Heart 101 (2015), 921–928.
11. 11 Wang, G.K., Zhu, J.Q., Zhang, J.T., Li, Q., Li, Y., He, J., et al. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J 31 (2010), 659–666.
12. 12 Rayner, K., Dimmeler, S., Calin, G.A., Thum, T., Raizman, J.E., Diamandis, E.P., Novel biomarkers for acute myocardial infarction: is microRNA the new kid on the block?. Clin Chem 60 (2014), 812–817.
13. 13 Lacolley, P., Regnault, V., Nicoletti, A., Li, Z., Michel, J.B., The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles. Cardiovasc Res 95 (2012), 194–204.
14. 14 de Gonzalo-Calvo, D., Cenarro, A., Martinez-Bujidos, M., Badimon, L., Bayes-Genis, A., Ordonez-Llanos, J., et al. Circulating soluble low-density lipoprotein receptor-related protein 1 (sLRP1) concentration is associated with hypercholesterolemia: a new potential biomarker for atherosclerosis. Int J Cardiol 201 (2015), 20–29.
15. 15 Hulsmans, M., Holvoet, P., MicroRNA-containing microvesicles regulating inflammation in association with atherosclerotic disease. Cardiovasc Res 100 (2013), 7–18.
16. 16 Llorente-Cortés, V., Martínez-González, J., Badimon, L., Esterified cholesterol accumulation induced by aggregated LDL uptake in human vascular smooth muscle cells is reduced by HMG-CoA reductase inhibitors. Arterioscler Thromb Vasc Biol 18 (1998), 738–746.
17. 17 Gómez-Gerique, J.A., Gutierrez-Fuentes, J.A., Montoya, M.T., Porres, A., Rueda, A., Avellaneda, A., et al. Lipid profile of the Spanish population: the DRECE (diet and risk of cardiovascular disease in Spain) study. DRECE study group. Med Clin (Barc) 113 (1999), 730–735.
18. 18 Palacios, L., Grandoso, L., Cuevas, N., Olano-Martin, E., Martinez, A., Tejedor, D., et al. Molecular characterization of familial hypercholesterolemia in Spain. Atherosclerosis 221 (2012), 137–142.
19. 19 Cordes, K.R., Sheehy, N.T., White, M.P., Berry, E.C., Morton, S.U., Muth, A.N., et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 460 (2009), 705–710.
20. 20 Liu, X., Cheng, Y., Zhang, S., Lin, Y., Yang, J., Zhang, C., A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ Res 104 (2009), 476–487.
21. 21 Corsten, M.F., Dennert, R., Jochems, S., Kuznetsova, T., Devaux, Y., Hofstra, L., et al. Circulating microRNA-208b and microRNA-499 reflect myocardial damage in cardiovascular disease. Circ Cardiovasc Genet 3 (2010), 499–506.
22. 22 Derda, A.A., Thum, S., Lorenzen, J.M., Bavendiek, U., Heineke, J., Keyser, B., et al. Blood-based microRNA signatures differentiate various forms of cardiac hypertrophy. Int J Cardiol 196 (2015), 115–122.
23. 23 Fichtlscherer, S., De Rosa, S., Fox, H., Schwietz, T., Fischer, A., Liebetrau, C., et al. Circulating microRNAs in patients with coronary artery disease. Circ Res 107 (2010), 677–684.
24. 24 Oerlemans, M.I., Mosterd, A., Dekker, M.S., de Vrey, E.A., van Mil, A., Pasterkamp, G., et al. Early assessment of acute coronary syndromes in the emergency department: the potential diagnostic value of circulating microRNAs. EMBO Mol Med 4 (2012), 1176–1185.
25. 25 Zampetaki, A., Kiechl, S., Drozdov, I., Willeit, P., Mayr, U., Prokopi, M., et al. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res 107 (2010), 810–817.
26. 26 Zampetaki, A., Willeit, P., Drozdov, I., Kiechl, S., Mayr, M., Profiling of circulating microRNAs: from single biomarkers to re-wired networks. Cardiovasc Res 93 (2012), 555–562.
27. 27 Llorente-Cortés, V., Otero-Viñas, M., Camino-López, S., Llampayas, O., Badimon, L., Aggregated low-density lipoprotein uptake induces membrane tissue factor procoagulant activity and microparticle release in human vascular smooth muscle cells. Circulation 110 (2004), 452–459.
28. 28 Vickers, K.C., Palmisano, B.T., Shoucri, B.M., Shamburek, R.D., Remaley, A.T., MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 13 (2011), 423–433.
29. 29 Zhang, Y., Liu, D., Chen, X., Li, J., Li, L., Bian, Z., et al. Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol Cell 39 (2010), 133–144.
30. 30 Waldenström, A., Genneback, N., Hellman, U., Ronquist, G., Cardiomyocyte microvesicles contain DNA/RNA and convey biological messages to target cells. PLoS ONE, 7, 2012, e34653.
31. 31 Zhou, J., Li, Y.S., Nguyen, P., Wang, K.C., Weiss, A., Kuo, Y.C., et al. Regulation of vascular smooth muscle cell turnover by endothelial cell-secreted microRNA-126: role of shear stress. Circ Res 113 (2013), 40–51.
32. 32 Diehl, P., Fricke, A., Sander, L., Stamm, J., Bassler, N., Htun, N., et al. Microparticles: major transport vehicles for distinct microRNAs in circulation. Cardiovasc Res 93 (2012), 633–644.
33. 33 Zampetaki, A., Mayr, M., MicroRNAs in vascular and metabolic disease. Circ Res 110 (2012), 508–522.
34. 34 Boon, R.A., Vickers, K.C., Intercellular transport of microRNAs. Arterioscler Thromb Vasc Biol 33 (2013), 186–192.
35. 35 Li, T., Cao, H., Zhuang, J., Wan, J., Guan, M., Yu, B., et al. Identification of miR-130a, miR-27b and miR-210 as serum biomarkers for atherosclerosis obliterans. Clin Chim Acta 412:1–2 (2011), 66–70.
36. 36 Jiang, Y., Wang, H.Y., Cao, H.M., Wang, C.Y., Zhang, L., Wang, H., et al. Peripheral blood miRNAs as a biomarker for chronic cardiovascular diseases. Sci Rep, 4, 2014, 5026.
37. 37 Zhang, X., Shao, S., Geng, H., Yu, Y., Wang, C., Liu, Z., et al. Expression profiles of six circulating microRNAs critical to atherosclerosis in patients with subclinical hypothyroidism: a clinical study. J Clin Endocrinol Metab 99 (2014), E766–E774.
38. 38 Finn, N.A., Eapen, D., Manocha, P., Al Kassem, H., Lassegue, B., Ghasemzadeh, N., et al. Coronary heart disease alters intercellular communication by modifying microparticle-mediated microRNA transport. FEBS Lett 587 (2013), 3456–3463.
39. 39 Jansen, F., Yang, X., Proebsting, S., Hoelscher, M., Przybilla, D., Baumann, K., et al. MicroRNA expression in circulating microvesicles predicts cardiovascular events in patients with coronary artery disease. J Am Heart Assoc, 3, 2014, e001249.
40. 40 Leroyer, A.S., Isobe, H., Leseche, G., Castier, Y., Wassef, M., Mallat, Z., et al. Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. J Am Coll Cardiol 49 (2007), 772–777.
41. 41 Climent, M., Quintavalle, M., Miragoli, M., Chen, J., Condorelli, G., Elia, L., TGFbeta triggers miR-143/145 transfer from smooth muscle cells to endothelial cells, thereby modulating vessel stabilization. Circ Res 116 (2015), 1753–1764.